Project Grant HT94252510443
Award Date
7/15/25
Completion Date
7/14/27
Dollars Obligated
$624K
Federal Agency
Defense Health Agency
Federal Grant Program
12.420
Assistance Type
Project Grant
Place of Performance
William Penn Annex West, PA 19107, USA
Similar Awards
The federal Project Grant award of $3,120,000.00 from the Defense Health Agency's Military Medical Research and Development program (CFDA 12.420) supports research conducted by Thomas Jefferson University's Sidney Kimmel Medical College on novel tumor-targeted immunotherapies against metastatic uveal melanoma. This 4-year award, running from September 1, 2025 to August 31, 2029, aims to transform healthcare for military service members, veterans, and the broader public through innovative...
This federal Project Grant award of $858,000.00 from the Department of the Army Medical Command under the Military Medical Research and Development (CFDA 12.420) program supports a longitudinal analysis of the mesenchymal cell state from melanoma initiation to metastatic progression at Thomas Jefferson University's Sidney Kimmel Medical College. The award, effective August 1, 2024, with a completion date of July 31, 2027, funds advanced biomedical research aimed at transforming healthcare for...
The U.S. Department of Defense's Defense Health Agency awarded a $780,000 Project Grant to Thomas Jefferson University, doing business as Sidney Kimmel Medical College, for a 3-year research project titled "DEGRADATION OF MUTANT GNAQ 11 IN UVEAL MELANOMA CELLS". The grant is funded through the Military Medical Research and Development program (CFDA 12.420), which supports biomedical research related to military medicine, including cancer, neurological disorders, and other conditions...
The Defense Health Agency awarded a $756,897 Project Grant to Thomas Jefferson University, doing business as the Sidney Kimmel Medical College, for the federal grant program "Military Medical Research and Development" (CFDA 12.420). The grant, effective August 1, 2024 through July 31, 2027, will support "Second-Generation Precision Medicine for BRCA-Mutant Ovarian Cancer" research. Thomas Jefferson University, a leading academic medical center known for its innovative medical...
The Department of the Army Medical Command awarded Thomas Jefferson University a $841,473 project grant under the Military Medical Research and Development program (CFDA 12.420). The grant will fund research from July 1, 2022 to June 30, 2026 to develop occult colorectal cancer elimination through GUCY2C-directed immunotherapy. The Military Medical Research and Development program supports basic, applied, and advanced biomedical research to transform military and public health care through...
The Department of Defense's Defense Health Agency awarded a $783,023 Project Grant under the Military Medical Research and Development (CFDA 12.420) program to The Henry M. Jackson Foundation For The Advancement Of Military Medicine, Inc. The grant supports a 3-year research project titled "A Precision-Medicine Approach to Targeting Acquired Therapeutic Resistance in RTK-Mutated NSCLC". This research aims to transform healthcare for military service members, veterans, and the broader...
The Defense Health Agency awarded a $682,049 Project Grant to The Washington University under the Military Medical Research and Development program (CFDA 12.420). The grant will fund a research project from August 1, 2023 to July 31, 2026 to leverage a precision medicine platform to predict novel therapies for malignant peripheral nerve sheath tumors. The Military Medical Research and Development program supports basic, applied, and advanced biomedical research to transform military and public...
This federal Project Grant award for $1,178,136.00, provided by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420), supports research by the University of Pennsylvania to exploit the absence of TP53 mutations in epithelial ovarian cancer using next-generation p53-stabilizing agents. The award has a performance period from April 15, 2025 to April 19, 2029 and aims to transform healthcare for military service members, veterans, and the broader...
This Project Grant award of $819,000.00 was provided by the Defense Health Agency through the Military Medical Research and Development (CFDA 12.420) program. The funding supports advanced biomedical research by Thomas Jefferson University, doing business as Sidney Kimmel Medical College, to investigate the role of chromium (VI)-driven profibrotic microenvironment and its contribution to lung carcinogenesis. The research aims to transform healthcare for military service members, veterans, and...
The Department of Defense's Defense Health Agency awarded a $558,832 Project Grant to Tufts University School of Medicine under the Military Medical Research and Development program (CFDA 12.420) on September 30, 2024. This grant will support research focused on "Targeting Differentiation Epitope in CD11b of Tumor-Associated Inflammatory Monocytes: A Novel Adjuvant Dendritic Cell Therapy Approach for Mucosal Melanoma." The research aims to develop an innovative dendritic cell-based...